PHASE ZERO

USPTO USPTO 1998 REGISTERED AND RENEWED

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke PHASE ZERO wurde als Wortmarke am 19.10.1998 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 20.04.2004 im Markenregister eingetragen. Der aktuelle Status der Marke ist "REGISTERED AND RENEWED".

Markendetails Letztes Update: 27. Juli 2019

Markenform Wortmarke
Aktenzeichen 75573307
Registernummer 2833467
Anmeldedatum 19. Oktober 1998
Veröffentlichungsdatum 20. Januar 2004
Eintragungsdatum 20. April 2004

Markeninhaber

6-8 UNDERWOOD STREET
N1 7JQ LONDON
GB

Markenvertreter

Waren und Dienstleistungen

9 COMPUTER SOFTWARE, NAMELY COMPUTER SOFTWARE FOR ANALYSIS, INTERPRETATION AND PRESENTATION OF INFORMATION PERTAINING TO PRE-CLINICAL, CLINICAL AND PHARMACEUTICAL RESEARCH; ELECTRONIC COMPUTER DATABASES FOR USE IN DRUG DISCOVERY AND DRUG RESEARCH AND FOR RESEARCH INTO HUMAN GENE DISTRIBUTION AND FUNCTION RECORDED ON CD-ROM, HARD DISK, AND SERVERS, AND DOWNLOADABLE VIA A GLOBAL COMPUTER NETWORK; ELECTRONIC PUBLICATIONS IN THE NATURE OF TEST REPORTS, MAGAZINES AND MANUALS FEATURING PRE-CLINICAL, CLINICAL AND PHARMACEUTICAL RESEARCH RECORDED ON CD-ROM, HARD DISK, AND SERVERS, AND DOWNLOADABLE VIA A GLOBAL COMPUTER NETWORK; SUPERFUSION APPARATUS USEABLE IN BIOLOGICAL, PHYSIOLOGICAL, MEDICAL AND CHEMICAL EXPERIMENTS, NAMELY MEASURING AND TESTING APPARATUS AND[REPLACEMENTS] * REPLACEMENT*PARTS [THEREFORE] * THEREFOR*
16 Printed publications, namely, books, reports, manuals, research papers relating to drug discovery programs, pre-clinical and clinical screening programs and pharmaceutical research programs; printed educational and teaching materials relating to pre-clinical, clinical and pharmaceutical research; and computer manuals and computer handbooks for use with computer databases in the field [for use with computer databases in the field] of drug discovery and drug research
42 DRUG DISCOVERY SERVICES, NAMELY, PHARMACEUTICAL RESEARCH SERVICES, PRE-CLINICAL SCREENING AND CLINICAL RESEARCH AND PHARMACEUTICAL EVALUATION SERVICES; BIOINFORMATICS, GENOMICS, PROTEOMICS, AND PHARMACOLOGY RESEARCH SERVICES; DEVELOPMENT OF HUMAN DISEASE MODELS FOR USE IN EVALUATION OF DRUGS AND DISCOVERY OF NEW DRUGS; PROVIDING ON-LINE COMPUTER DATABASES FOR USE IN PHARMACEUTICAL RESEARCH; PROVIDING ON-LINE DATABASES FOR USE IN RESEARCH INTO HUMAN GENE AND HUMAN PROTEIN FUNCTIONS; COMPUTER MODELING FOR ANALYZING, INTERPRETING AND PRESENTING BIOLOGICAL, PHYSIOLOGICAL AND CHEMICAL PROCESSES THAT RELATE TO PRE-CLINICAL, CLINICAL AND PHARMACEUTICAL RESEARCH; THE PREPARATION AND DISSEMINATION OF INFORMATION, AND ADVISORY AND CONSULTATION SERVICES RELATING TO ALL OF THE AFORESAID SERVICES; ON-LINE PUBLICATIONS, NAMELY TEST REPORTS, MAGAZINES AND MANUALS FEATURING PRE-CLINICAL, CLINICAL AND PHARMACEUTICAL RESEARCH
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1375573307